L1CAM and cancer: In the univariate survival analysis the 11% L1CAM positive cancers exhibited an unfavourable DFS (median value 1.21 (Q1-Q3 0.50-2.13) years VS 8.63 (Q1-Q3 2.48-14.62) years; p=0.005) and OS (median value 3.51 (Q1-Q3 1.11-8.43) years VS 12.12 (Q1-Q3 5.83-16.06) years p=0.020); (Figure 2A and 2B).